Aberrant splicing has been identified as the mechanism by which KIF5A mutations cause ALS through a toxic gain-of-function, leading to the aggregation of KIF5A in distal axons and thus to neuronal toxicity. Here, KIF5A is linked to amyotrophic lateral sclerosis.